BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 30833373)

  • 1. Long-term Association of Depression Symptoms and Antidepressant Medication Use With Incident Cardiovascular Events in the Look AHEAD (Action for Health in Diabetes) Clinical Trial of Weight Loss in Type 2 Diabetes.
    Hazuda HP; Gaussoin SA; Wing RR; Yanovski SZ; Johnson KC; Coday M; Wadden TA; Horton ES; Van Dorsten B; Knowler WC;
    Diabetes Care; 2019 May; 42(5):910-918. PubMed ID: 30833373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Four-year analysis of cardiovascular disease risk factors, depression symptoms, and antidepressant medicine use in the Look AHEAD (Action for Health in Diabetes) clinical trial of weight loss in diabetes.
    Rubin RR; Peyrot M; Gaussoin SA; Espeland MA; Williamson D; Faulconbridge LF; Wadden TA; Ewing L; Safford M; Evans-Hudnall G; Wing RR; Knowler WC;
    Diabetes Care; 2013 May; 36(5):1088-94. PubMed ID: 23359362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular disease risk factors, depression symptoms and antidepressant medicine use in the Look AHEAD (Action for Health in Diabetes) clinical trial of weight loss in diabetes.
    Rubin RR; Gaussoin SA; Peyrot M; DiLillo V; Miller K; Wadden TA; West DS; Wing RR; Knowler WC;
    Diabetologia; 2010 Aug; 53(8):1581-9. PubMed ID: 20422396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of intensive lifestyle intervention on depression and health-related quality of life in type 2 diabetes: the Look AHEAD Trial.
    Rubin RR; Wadden TA; Bahnson JL; Blackburn GL; Brancati FL; Bray GA; Coday M; Crow SJ; Curtis JM; Dutton G; Egan C; Evans M; Ewing L; Faulconbridge L; Foreyt J; Gaussoin SA; Gregg EW; Hazuda HP; Hill JO; Horton ES; Hubbard VS; Jakicic JM; Jeffery RW; Johnson KC; Kahn SE; Knowler WC; Lang W; Lewis CE; Montez MG; Murillo A; Nathan DM; Patricio J; Peters A; Pi-Sunyer X; Pownall H; Rejeski WJ; Rosenthal RH; Ruelas V; Toledo K; Van Dorsten B; Vitolins M; Williamson D; Wing RR; Yanovski SZ; Zhang P;
    Diabetes Care; 2014 Jun; 37(6):1544-53. PubMed ID: 24855155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of the magnitude of weight loss and changes in physical fitness with long-term cardiovascular disease outcomes in overweight or obese people with type 2 diabetes: a post-hoc analysis of the Look AHEAD randomised clinical trial.
    ; Gregg EW; Jakicic JM; Blackburn G; Bloomquist P; Bray GA; Clark JM; Coday M; Curtis JM; Egan C; Evans M; Foreyt J; Foster G; Hazuda HP; Hill JO; Horton ES; Hubbard VS; Jeffery RW; Johnson KC; Kitabchi AE; Knowler WC; Kriska A; Lang W; Lewis CE; Montez MG; Nathan DM; Neiberg RH; Patricio J; Peters A; Pi-Sunyer X; Pownall H; Redmon B; Regensteiner J; Rejeski J; Ribisl PM; Safford M; Stewart K; Trence D; Wadden TA; Wing RR; Yanovski SZ
    Lancet Diabetes Endocrinol; 2016 Nov; 4(11):913-921. PubMed ID: 27595918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of the dynamics of depression symptoms on outcomes after coronary artery bypass grafting.
    Foss-Nieradko B; Stepnowska M; Piotrowicz R
    Kardiol Pol; 2012; 70(6):591-7. PubMed ID: 22718378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective Association of GLUL rs10911021 With Cardiovascular Morbidity and Mortality Among Individuals With Type 2 Diabetes: The Look AHEAD Study.
    Look AHEAD Research Group
    Diabetes; 2016 Jan; 65(1):297-302. PubMed ID: 26395743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depressive symptoms, antidepressant medication use, and new onset of diabetes in participants of the diabetes prevention program and the diabetes prevention program outcomes study.
    Marrero DG; Ma Y; de Groot M; Horton ES; Price DW; Barrett-Connor E; Carnethon MR; Knowler WC;
    Psychosom Med; 2015 Apr; 77(3):303-10. PubMed ID: 25775165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of optimal phenomapping methods to estimate long-term atherosclerotic cardiovascular disease risk in patients with type 2 diabetes.
    Segar MW; Patel KV; Vaduganathan M; Caughey MC; Jaeger BC; Basit M; Willett D; Butler J; Sengupta PP; Wang TJ; McGuire DK; Pandey A
    Diabetologia; 2021 Jul; 64(7):1583-1594. PubMed ID: 33715025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective association of a genetic risk score and lifestyle intervention with cardiovascular morbidity and mortality among individuals with type 2 diabetes: the Look AHEAD randomised controlled trial.
    Look AHEAD Research Group
    Diabetologia; 2015 Aug; 58(8):1803-13. PubMed ID: 25972230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physical Activity and Weight Loss Among Adults With Type 2 Diabetes and Overweight or Obesity: A Post Hoc Analysis of the Look AHEAD Trial.
    Huang Z; Zhuang X; Huang R; Liu M; Xu X; Fan Z; Dai R; Li H; Xiong Z; Guo Y; Liang Q; Liao X
    JAMA Netw Open; 2024 Feb; 7(2):e240219. PubMed ID: 38386318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depressive Symptoms, Antidepressant Medication Use, and Inflammatory Markers in the Diabetes Prevention Program.
    de Groot M; Marrero D; Mele L; Doyle T; Schwartz F; Mather KJ; Goldberg R; Price DW; Ma Y; Knowler WC;
    Psychosom Med; 2018; 80(2):167-173. PubMed ID: 29016549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic Predictors of Depressive Symptoms in the Look AHEAD Trial.
    McCaffery JM; Papandonatos GD; Faulconbridge LF; Erar B; Peter I; Wagenknecht LE; Pajewski NM; Anderson A; Wadden TA; Wing RR;
    Psychosom Med; 2015; 77(9):982-92. PubMed ID: 26489030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and correlates of depressive disorders in elderly with type 2 diabetes in primary health care settings.
    Shehatah A; Rabie MA; Al-Shahry A
    J Affect Disord; 2010 Jun; 123(1-3):197-201. PubMed ID: 19804911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between antidepressant therapy and risk for cardiovascular events in patients with and without cardiovascular disease.
    Lavoie KL; Paine NJ; Pelletier R; Arsenault A; Diodati JG; Campbell TS; Pilote L; Bacon SL
    Health Psychol; 2018 Nov; 37(11):989-999. PubMed ID: 30247064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic Dyslipidemia and Cardiovascular Outcomes in Type 2 Diabetes Mellitus: Findings From the Look AHEAD Study.
    Kaze AD; Santhanam P; Musani SK; Ahima R; Echouffo-Tcheugui JB
    J Am Heart Assoc; 2021 Apr; 10(7):e016947. PubMed ID: 33728932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationships between cardiovascular disease risk factors and depressive symptoms as predictors of cardiovascular disease events in women.
    Rutledge T; Linke SE; Johnson BD; Bittner V; Krantz DS; Cornell CE; Vaccarino V; Pepine CJ; Handberg EM; Eteiba W; Shaw LJ; Parashar S; Eastwood JA; Vido DA; Merz CN
    J Womens Health (Larchmt); 2012 Feb; 21(2):133-9. PubMed ID: 21988550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association Between Depressive Symptoms and Incident Cardiovascular Diseases.
    Harshfield EL; Pennells L; Schwartz JE; Willeit P; Kaptoge S; Bell S; Shaffer JA; Bolton T; Spackman S; Wassertheil-Smoller S; Kee F; Amouyel P; Shea SJ; Kuller LH; Kauhanen J; van Zutphen EM; Blazer DG; Krumholz H; Nietert PJ; Kromhout D; Laughlin G; Berkman L; Wallace RB; Simons LA; Dennison EM; Barr ELM; Meyer HE; Wood AM; Danesh J; Di Angelantonio E; Davidson KW;
    JAMA; 2020 Dec; 324(23):2396-2405. PubMed ID: 33320224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular hazards of insufficient treatment of depression among patients with known cardiovascular disease: a propensity score adjusted analysis.
    Bangalore S; Shah R; Pappadopulos E; Deshpande CG; Shelbaya A; Prieto R; Stephens J; McIntyre RS
    Eur Heart J Qual Care Clin Outcomes; 2018 Oct; 4(4):258-266. PubMed ID: 29893803
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.